Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0MC3U
|
||||
Former ID |
DNC008435
|
||||
Drug Name |
N,N'-(1',10'-decylene)-bis-(-)-nor-MEP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529368] | ||
Structure |
Download2D MOL |
||||
Formula |
C38H60N2O2
|
||||
Canonical SMILES |
CCC1(CCCCN(C1)CCCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C<br />4=CC(=CC=C4)O
|
||||
InChI |
1S/C38H60N2O2/c1-3-37(33-19-17-21-35(41)29-33)23-11-15-27-39(31-37)25-13-9-7-5-6-8-10-14-26-40-28-16-12-24-38(4-2,32-40)34-20-18-22-36(42)30-34/h17-22,29-30,41-42H,3-16,23-28,31-32H2,1-2H3/t37-,38-/m1/s1
|
||||
InChIKey |
PCOSLLZEMYSIRZ-XPSQVAKYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529368] | |
Cholinesterase | Target Info | Inhibitor | [529368] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.